Holdings
吉帝藥品股份有限公司
As of Sep 30, 2026, 吉帝藥品股份有限公司 reported 2 positions. Largest: Pet Pharm Biotech Co., Ltd. and Steminent Biotherapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Pet Pharm Biotech Co., Ltd. | 2.77M | no change | Sep 30, 2026 | |
| Steminent Biotherapeutics, Inc. | 1.59M | no change | Sep 30, 2026 |